Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Bioinnovate Global AB
AB
Active
Org 5591006845
Bryggaregatan 17 D, 247 32
Södra Sandby
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 9 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Bioinnovate Global AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 2M
2M
2023
2024: 1M (-50% vs 2023)
1M
-50%
2024
EBITDA
SEK millions
2M
2M
1M
1M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 2M
2M
2023
2024: 1M (-50% vs 2023)
1M
-50%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
1 206
2 387
363
312
391
Staff expenses
−54
−44
−43
—
—
EBITDA
648
1 730
80
82
241
Depreciation & amort.
—
—
—
−0
−7
EBIT
648
1 730
80
82
234
Net financials
26
4
−0
—
—
Profit before tax
499
1 324
60
62
176
Tax
−110
−273
−12
−13
−38
Net profit
389
1 051
47
49
138
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
2 629
2 153
409
538
458
Equity
1 399
1 211
260
333
284
Long-term debt
—
—
—
0
0
Short-term debt
527
414
31
108
96
Total debt
527
414
31
108
96
Financial ratios
5-year trend
EBITDA margin
53,7 %
This company
15,8 %
Market median
This company
Market median
240% above market
2020
2024
Equity ratio
53,2 %
This company
38,2 %
Market median
This company
Market median
39% above market
2020
2024
Return on equity
27,8 %
This company
18,4 %
Market median
This company
Market median
51% above market
2020
2024
Net profit margin
32,2 %
This company
8,1 %
Market median
This company
Market median
298% above market
2020
2024
Asset turnover
0,46×
This company
1,12×
Market median
This company
Market median
59% below market
2020
2024
Debt / equity
0,88×
This company
0,62×
Market median
This company
Market median
42% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Bioinnovate Global AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
